相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication
Adam Cuker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
J. H. Levy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Direct oral anticoagulant drug level testing in clinical practice: A single institution experience
Karlyn Martin et al.
THROMBOSIS RESEARCH (2016)
Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations
Mojca Bozic-Mijovski et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods
Shanshan Du et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Real-world variability in dabigatran levels in patients with atrial fibrillation
N. C. Chan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Idarucizumab for Dabigatran Reversal
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Estimation of dabigatran plasma concentrations in the perioperative setting An ex vivo study using dedicated coagulation assays
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran
Charles V. Pollack et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations
Anne Godier et al.
THROMBOSIS RESEARCH (2015)
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience
Rohit Kumar et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2015)
Performance of Various Laboratory Assays in the Measurement of Dabigatran in Patients Receiving Therapeutic Doses A Prospective Study Based on Peak and Trough Plasma Levels
Robert Gosselin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management
H. Tran et al.
INTERNAL MEDICINE JOURNAL (2014)
Proposed Approach to Thrombolysis in Dabigatran-Treated Patients Presenting with Ischemic Stroke
Mahesh Kate et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
Paul A. Reilly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants
Adam Cuker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Measuring Dabigatran Concentrations Using a Chromogenic Ecarin Clotting Time Assay
Robert C. Gosselin et al.
ANNALS OF PHARMACOTHERAPY (2013)
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013
Gilles Pernod et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
T. Baglin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Practical management of patients on apixaban: a consensus guide
Christopher Ward et al.
THROMBOSIS JOURNAL (2013)
Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL
Armando Tripodi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Joanne van Ryn et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
Joachim Stangier
CLINICAL PHARMACOKINETICS (2008)
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
Joachim Stangier et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
分享论文
